Literature DB >> 7595112

Tender points/fibromyalgia vs. trigger points/myofascial pain syndrome: a need for clarity in terminology and differential diagnosis.

M J Schneider.   

Abstract

OBJECTIVE: This study reviews the clinical distinctions between fibromyalgia (FM) and myofascial pain syndrome (MPS), which represent two separate and distinct soft-tissue syndromes. The major aim of this article is to clarify the terminology associated with these syndromes and clearly define the parameters of differential diagnosis and treatment. DATA SOURCES: Pertinent articles in the chiropractic and medical literature are reviewed with an emphasis on the literature published from 1985-1994. STUDY SELECTION: Studies were selected that emphasized differential diagnosis of FM and MPS, as well as individual articles on either FM or MPS. DATA SYNTHESIS: The literature on fibromyalgia and myofascial pain syndromes has grown considerably since 1985. It is now clear that there are several important differences between FM and MPS. The most important criteria for differential diagnosis are the presence of tender points (TePs) and widespread, nonspecific, soft tissue pain in FM, compared with regional and characteristic referred pain patterns with discrete muscular trigger points (TrPs) and taut bands of skeletal muscle in MPS. The etiology of TePs is still unknown and it is uncertain which specific soft tissues are tender in FM patients. Myofascial TrPs are found within a taut band of skeletal muscle and have a characteristic "nodular" texture upon palpation. TrPs are thought to develop after trauma, overuse or prolonged spasm of muscles. Local treatment applied to TePs is ineffective, yet specific treatment of TrPs is often dramatically effective.
CONCLUSION: FM and MPS are two different clinical conditions that require different treatment plans. FM is a systemic disease process, apparently caused by dysfunction of the limbic system and/or neuroendocrine axis. It often requires a multidisciplinary treatment approach including psychotherapy, low dose antidepressant medication and a moderate exercise program. MPS is a condition that arises from the referred pain and muscle dysfunction caused by TrPs, which often respond to manual treatment methods such as ischemic compression and various specific stretching techniques. Both of these conditions are seen routinely in chiropractic offices; therefore, it is important for field practitioners to understand these distinctions.

Entities:  

Mesh:

Year:  1995        PMID: 7595112

Source DB:  PubMed          Journal:  J Manipulative Physiol Ther        ISSN: 0161-4754            Impact factor:   1.437


  6 in total

1.  Ischemic compression and joint mobilisation for the treatment of nonspecific myofascial foot pain: findings from two quasi-experimental before-and-after studies.

Authors:  Guy Hains; Pierre B Boucher; Anne-Marie Lamy
Journal:  J Can Chiropr Assoc       Date:  2015-03

2.  Increased absence due to sickness among employees with fibromyalgia.

Authors:  M Kivimäki; P Leino-Arjas; L Kaila-Kangas; M Virtanen; M Elovainio; S Puttonen; L Keltikangas-Järvinen; J Pentti; J Vahtera
Journal:  Ann Rheum Dis       Date:  2006-06-22       Impact factor: 19.103

3.  The relationship between the fear-avoidance model of pain and personality traits in fibromyalgia patients.

Authors:  María Pilar Martínez; Ana Isabel Sánchez; Elena Miró; Ana Medina; María José Lami
Journal:  J Clin Psychol Med Settings       Date:  2011-12

4.  A comparison of the clinical manifestation and pathophysiology of myofascial pain syndrome and fibromyalgia: implications for differential diagnosis and management.

Authors:  Sheryl Bourgaize; Genevieve Newton; Dinesh Kumbhare; John Srbely
Journal:  J Can Chiropr Assoc       Date:  2018-04

Review 5.  Diagnostic confounders of chronic widespread pain: not always fibromyalgia.

Authors:  Winfried Häuser; Serge Perrot; Claudia Sommer; Yoram Shir; Mary-Ann Fitzcharles
Journal:  Pain Rep       Date:  2017-04-30

Review 6.  Limited Utility for Benzodiazepines in Chronic Pain Management: A Narrative Review.

Authors:  Steven L Wright
Journal:  Adv Ther       Date:  2020-05-06       Impact factor: 3.845

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.